# Acute Hip Fracture Study in Patients 65 Years or Greater

> **NCT02578095** · PHASE2 · COMPLETED · sponsor: **Viking Therapeutics, Inc.** · enrollment: 108 (actual)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** VK5211
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02578095
- **Lead sponsor:** Viking Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-30
- **Primary completion:** 2017-11-15
- **Final completion:** 2017-12-17
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578095, "Acute Hip Fracture Study in Patients 65 Years or Greater". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02578095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*